LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
about
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseImpaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceHeterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson diseaseMembrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylationAdult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S miceTen years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinicGenetics of Parkinson's disease - a clinical perspectiveIs inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseParkinson's Disease and Cognitive ImpairmentConditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegenerationLRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats.Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.LRRK2 variation and Parkinson's disease in African Americans.Parkinson's disease: Exit toxins, enter geneticsNovel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.Clinical expression of LRRK2 G2019S mutations in the elderly.Genetic variants ofLRRK2 in Taiwanese Parkinson's diseaseReorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers.A comparative study of Lrrk2 function in primary neuronal cultures.Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson's diseaseAssociation of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.Novel recruitment strategy to enrich for LRRK2 mutation carriersThe Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and PathologyInhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localizationLeucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.Targets for neuroprotection in Parkinson's diseaseEmerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization.Genetics of Parkinson disease and essential tremorLRRK2, a puzzling protein: insights into Parkinson's disease pathogenesisGenetics and genomics of Parkinson's disease.
P2860
Q22242985-582AEF0F-CEB3-4103-9064-DA15BDEF6C7AQ24293070-E893CD79-BC25-41AE-8B87-D47394B7C120Q24298781-26FE88D4-B18B-4FE2-8ED1-A629BC139782Q24316270-9B5B93B8-B357-4084-B698-51470DBF825CQ24317631-716A5FAE-1386-468F-9B1D-921FC4857487Q27007413-551AF0C5-A773-4962-8C56-0305B2D47AADQ27022109-53FF4201-D12B-4C94-9A84-D7FBF7F915A9Q27026262-3AEA8D01-848B-47C4-91B2-156ABF2DF02EQ27308060-C8D640BD-DF14-428F-910A-7429CB4AD2B5Q28388674-5B95FBCA-E5EB-4EF9-A30F-C3892850A8A9Q30239814-0B3E08B4-EDE7-4E16-AADC-D9EC67D786C1Q30653185-B06DB406-7DF0-4FFA-9BF7-E5A479C52E1AQ33382857-8B44187A-1C3B-4E47-8E4D-58E611E865DCQ33561039-A90193B8-4477-410F-B075-12D55BE380ACQ33835006-3ADC0219-53E2-4A16-84C7-CE49C0E6DC89Q33884044-24621E89-A163-47C0-B3D3-F55C21DFD9A5Q34079325-B3B73729-10F8-4DDF-BB74-E38AB9DCC1E6Q34126355-4C221DE3-D85D-47EA-817C-42507BBEC25DQ34140428-19C3A6C6-44A2-4DE8-96F9-88B6E46E93E7Q34267681-4EEA0D53-3AA1-4039-8A21-E11D51369FA5Q34267725-6EC714A0-AA62-4E62-B96C-56FCA6E20EE4Q34300290-0DB705D5-935E-45C1-8796-9FC10056C295Q35067666-63D4C698-6E28-4FB5-A2C6-D454FCB5414DQ35106295-0A1DCD90-798C-4CDE-9529-591E36DD63BBQ35176338-CDD9B4A6-65A6-4E20-BBAF-B4446BEBC7B4Q35240670-7F0716F4-8D55-4A10-AEEF-4A77A7DDCA82Q35525896-9606A7EE-1B16-4017-A3F4-2C39D18F17E1Q35781883-5F883C54-D49E-46F6-912C-5E0D54386829Q35850713-062A1045-1530-45D4-B562-114C59D8D74CQ36098631-4AF51804-C436-40CB-99F6-3152A3EC3764Q36475393-E33D1C2D-536D-4774-8975-606BB178A335Q36780383-49B449BB-8ACF-4EA8-878F-57550B1470ACQ37225356-B1F91D3F-8297-4C03-83FE-75800DDFA76CQ37302453-FB7F49A6-25F9-4887-8A77-AA562C97E99DQ37330540-32A1A539-5738-4D0D-BB0C-D7D6F16271CFQ37402225-594EC018-C380-4318-B9BD-DAA634C8F9F8Q37479332-38E467AB-AA38-4723-9DDE-1E9E00CBEB4DQ37594762-7097D880-D89B-4FC9-B5D4-A12D6D723049Q38218398-A47D774C-AC93-4385-89AF-1B71EF144F90Q38233866-80063CFF-BFE7-4596-AFEF-8E710C1E5B96
P2860
LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@en
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@nl
type
label
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@en
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@nl
altLabel
LRRK2 Gly2019Ser penetrance in ...... : a case-control genetic study
@en
prefLabel
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@en
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@nl
P2093
P50
P1433
P1476
LRRK2 Gly2019Ser penetrance in ...... a case-control genetic study.
@en
P2093
Fayçal Hentati
Ghada El Euch-Fayeche
Lefkos T Middleton
Mounir Kefi
Mourad Zouari
Rab K Prinjha
Rim Amouri
Ruchi Upmanyu
Samia Ben Sassi
Samia Ben Yahmed
P304
P356
10.1016/S1474-4422(08)70116-9
P4011
5e6a0dab4808a3ed6e37c56f11a38b3b489bac2d
P407
P50
P577
2008-06-06T00:00:00Z